Details
Pramistar Indications
Decreased ability to concentrate; memory impairment degenerative or vascular origin, particularly in the elderly.
Contradictions
Hypersensitivity to the active substance or other components of the drug, bleeding in the brain, severe kidney failure, liver failure, pregnancy and lactation.
Dosage & Administration
Oral administration, of 1 tablet 2 times a day. Clinically significant effect can be expected no earlier than 4-8 weeks of treatment.
Elderly patients. Dose adjustment is not needed.
Patients with renal failure. In renal insufficiency excretion pramiratsetama point decline, the clinical significance of which is not defined, therefore use in patients with renal insufficiency should be under the control of kidney function and the development of side effects cancel it, as this may be signs of accumulation of the active substance in the body.
